does tirzepatide cause muscle wasting Mounjaro and Loss: What the SURMOUNT-1 Study Shows Tirzepatide‐induced changes in skeletal muscle

Basotti G, et al

Based on a study conducted on 2,539 adults, after 12 weeks of Tirzepatide treatment, researchers categorized participants as "early responders" if they had lost at least 5% of their body weight, and as "slow responders" if they had lost less than 5% of their body weight

,

Tirzepatide reduced symptoms of OPS by nearly two-thirds, or 66% in some adults, while a placebo only resulted in a reduction of 5%

16-18 Nausea is the most frequently reported AE among GLP-1 RAs, with rates ranging from 20% to 40% depending on the agent and dose

FUJIFILM Wako, Prod No: 019-19741) and the glial fibrillary acidic protein (GFAP